The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
June 4th 2023
A new-user, active comparator cohort study from EULAR 2023 suggests use of SGLT2 inhibitors could lower risk of recurrent gout flares in people with type 2 diabetes and gout compared to use of DPP-4 inhibitors.
Risankizumab Provides Durable Quality of Life Improvements out to 100 Weeks in Psoriatic ArthritisJune 1st 2023
An analysis of 100 week data from the KEEPsAKE 1 and 2 trials presented at EULAR 2023 offers insight into the long-term effects of risankizumab use in people with psoriatic arthritis.
Study Shows Pegloticase Plus Methotrexate Improves Quality of Life in Gout PatientsJune 1st 2023
An analysis of patient-reported outcomes data from the MIRROR trial offers insight into the effects of pegloticase plus methotrexate on quality of life and various disease activity indices.
Achieving Remission with Methotrexate or TNFi Linked to Lower CV Risk in Rheumatoid ArthritisMay 31st 2023
An analysis of patient data from Sweden and Norway detail the impact of achieving remission with methotrexate or TNF inhibitors on risk of acute coronary syndrome in patients with rheumatoid arthritis.
BE VITAL: Bimekizumab Helps Control, Attenuate Disease Activity in Psoriatic ArthritisMay 31st 2023
Data from the BE VITAL OLE study, which included patients from the BE COMPLETE and BE OPTIMAL studies, suggests the benefits of bimekizumab in patients with psoriatic arthritis with inadequate response or intolerance to TNF inhibitors were sustained for up to 52 weeis.
Janssen Develops Programs to Support Health Equity in Psoriatic DiseaseMay 25th 2023
The disparities compelled them to launch Determi-Nation, which utilizes healthcare providers, advocates, and patients within the psoriatic disease community to co-create solutions that address the observed inequities.
Patients with Psoriatic Disease Report Discordance with Provider over Treatment GoalsMay 18th 2023
Leveraging data from the 2020 UPLIFT survey, investigators offer an overview of the quality of life and treatment satisfaction among people with psoriasis and psoriatic arthritis in the US.
Study Offers Overview of Features, Outcomes, Treatment for Immune-Mediated Necrotizing MyopathyMay 8th 2023
A study leveraging DoD data provides a comprehensive overview of clinical features, treatment choices, and outcomes of patients with immune mediated necrotizing myopathy relative to those of patients with other idiopathy inflammatory myopathies.
RAIL Score Provides Useful, Noninvasive Biomarker for Renal Disease ActivityMay 7th 2023
An analysis of data obtained from urine samples in the MUSE and TULIP-1 trial sheds new light on the clinical utility of the RAIL score for identifying disease activity and treatment responders in SLE patients with and without lupus nephritis, respectively
Study Underlines Potential of IL-6 Inhibitors for Polymyalgia RheumaticaMay 7th 2023
An analysis of Medcare claims data offers clinicians an overview or the effectiveness of sarilumab and tocilizumab in second- and third-line polymyalgia rheumatica treatments relative to conventional immunomodulators, such as methotrexate or azathioprine.
CCR East: Study Offers Overview of Pregnancy Outcomes in Takayasu ArteritisMay 7th 2023
An analysis of data from the National Inpatient Sample offers an overview of risk for adverse delivery outcomes associated with Takayasu arteritis among a real-world cohort of US-based patients.
Vitamin D Levels Can Influence Risk of Miscarriage, Premature Delivery in Women with LupusMay 6th 2023
An analysis of more than 250 pregnancies among women with SLE from the Hopkins Lupus Cohort provides insight into risk of adverse pregnancy outcomes based on serum 25-hydroxy vitamin D levels using real-world data.
Dermatomyositis, Polymyositis Linked to Doubling in Risk of Mortality in Heart Failure PatientsMay 6th 2023
An analysis of the National Inpatient Sample offers a deep dive into the risk of adverse outcomes associated with presence of polymyositis or dermatomyositis among patients with congestive heart failure.
Renal Biopsy Data Supports Long-Term Voclosporin Use for Lupus NephritisMay 5th 2023
Data from an analysis of kidney biopsies from the AURORA 2 trial presented at CCR East 2023 offer new insight into the long-term histological impact of voclosporin use on renal function in patients with lupus nephritis.